NCI Agrees To give NSABP One Year Until Competition; Advisors OK Concept
In Brief: William Blot, Michael Grever, Others To Leave NCI; RAC Approves Naked DNA Vaccine Trial
DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects
Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume
House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI
NCI Audit Finds “Low Quality” Research At Calif. Foundation
DCE Board Approves Study of Breast Cancer On Long Island
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









